Cargando…
A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19 vaccine associated with muscle weakness
Autores principales: | Kim, Chul Soo, Kwak, Jae Gyu, Jang, Seongsoo, Bang, Soo-Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958373/ https://www.ncbi.nlm.nih.gov/pubmed/35342039 http://dx.doi.org/10.5045/br.2022.2021134 |
Ejemplares similares
-
Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia
por: Bang, Soo-Mee, et al.
Publicado: (2021) -
Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura
por: Bae, Sung Hwa, et al.
Publicado: (2022) -
Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19
por: Jang, Hee Ryeong, et al.
Publicado: (2021) -
A case report of thrombotic thrombocytopenic purpura-like syndrome after Coronavirus disease 2019 vaccination
por: Noh, Sua, et al.
Publicado: (2023) -
Vaccine-Induced Immune Thrombotic Thrombocytopenia: First Case Report in South Korea
por: Kim, Min Kyung, et al.
Publicado: (2021)